clinical test

(Elsevier Health Sciences) The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients.

In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

An article published in the April issue of Urology is a step in this direction as researchers from Emory University report the successful development of an experimental clinical test for XMRV.

MIAMI BEACH (MedPage Today) -- In its first clinical test, a novel anti-inflammatory molecule appears to be safe, even at relatively high doses, a researcher said here.